These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37801862)
1. Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma. Tuna M; Mills GB; Amos CI Neoplasia; 2023 Nov; 45():100932. PubMed ID: 37801862 [TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma. Tuna M; Liu W; Amos CI; Mills GB Neoplasia; 2019 Nov; 21(11):1102-1109. PubMed ID: 31734631 [TBL] [Abstract][Full Text] [Related]
3. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
4. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma. Liu B; Chen Y; Yang J Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974 [TBL] [Abstract][Full Text] [Related]
5. Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation. Tuna M; Amos CI; Mills GB Neoplasia; 2022 Mar; 25():9-17. PubMed ID: 35065533 [TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of acquired uniparental disomy in serous ovarian cancer. Tuna M; Ju Z; Smid M; Amos CI; Mills GB Mol Cancer; 2015 Feb; 14(1):29. PubMed ID: 25644622 [TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations. Tuna M; Amos CI; Mills GB Neoplasia; 2019 Feb; 21(2):197-205. PubMed ID: 30616092 [TBL] [Abstract][Full Text] [Related]
8. Co-occurrence of CDKN2A/B and IFN-I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma. Peng Y; Chen Y; Song M; Zhang X; Li P; Yu X; Huang Y; Zhang N; Ji L; Xia L; Xia X; Yi X; Tan B; Yang Z Mol Oncol; 2022 Apr; 16(8):1746-1760. PubMed ID: 35253368 [TBL] [Abstract][Full Text] [Related]
9. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
10. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
11. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. Yin D; Zhang Y; Li H; Cheng L Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446 [TBL] [Abstract][Full Text] [Related]
12. Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes. Fang X; Li D; Wan S; Hu J; Zhang P; Jie D; Chen L; Jiang G; Song N J Gene Med; 2024 Jun; 26(6):e3694. PubMed ID: 38847309 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Zengin T; Önal-Süzek T J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117 [TBL] [Abstract][Full Text] [Related]
14. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. Yu H; Pang Z; Li G; Gu T J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722 [TBL] [Abstract][Full Text] [Related]
16. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates. Meng F; Zhang L; Ren Y; Ma Q J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039 [TBL] [Abstract][Full Text] [Related]
17. Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients. Ding Y; Zhang L; Guo L; Wu C; Zhou J; Zhou Y; Ma J; Li X; Ji P; Wang M; Zhu W; Shi C; Li S; Wu W; Zhu W; Xiao D; Fu C; He Q; Sun R; Mao X; Lizaso A; Li B; Han-Zhang H; Zhang Z Thorac Cancer; 2020 Jan; 11(1):103-112. PubMed ID: 31692283 [TBL] [Abstract][Full Text] [Related]
18. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. Xu X; Zhang J; Yao T; Zhao X; Wu Q; Lu C; Guo X; Xie S; Qiu L; Bi R; Xue H Int Immunopharmacol; 2024 Sep; 139():112727. PubMed ID: 39067405 [TBL] [Abstract][Full Text] [Related]
19. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
20. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Wang J; Zhan X Front Immunol; 2021; 12():752643. PubMed ID: 34887858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]